Skip to main content
. 2014 Sep 30;37(10):597–604. doi: 10.1002/clc.22327

Table 3.

Baseline Characteristics and Lipid Parameters

OPTIONS I, n = 355 OPTIONS II, n = 305
Characteristic
Age (SD), y 62.9 (10.2) 60.9 (10.3)
Male, n (%) 231 (65.1) 187 (61.3)
Race, n (%)
White 306 (86.2) 256 (83.9)
Black 38 (10.7) 27 (8.9)
Other 11 (3.1) 22 (7.2)
BMI (SD), kg/m2 31.0 (6.4) 31.3 (6.6)
CHD, n (%) 211 (59.4) 192 (63.0)
DM, n (%) 178 (50.1) 128 (42.0)
Hypertension, n (%) 278 (78.3) 221 (72.5)
Current smoker, n (%) 66 (18.6) 56 (18.4)
Lipid parameters
LDL‐C (SD), mg/dL 105.1 (34.1) 111.3 (39.0)
TC (SD), mg/dL 182.0 (39.0) 191.1 (44.7)
HDL‐C (SD), mg/dL 48.7 (13.4) 50.0 (13.1)
Fasting TG, median (Q1:Q3), mg/dL 140.7 (89.0:175.0) 128.0 (92.0:185.0)
Non–HDL‐C (SD), mg/dL 133.3 (38.8) 141.1 (43.4)
Apo B (SD), mg/dL 90.8 (23.2) 95.3 (24.1)
Apo A‐1 (SD), mg/dL 144.2 (23.8) 146.2 (25.0)
Lp(a), median (Q1:Q3), mg/dL 44.8 (8.0:68.0) 28.0 (11.0:79.0)

Abbreviations; Apo, apolipoprotein; BMI, body mass index; CHD, coronary heart disease; DM, diabetes mellitus; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; Lp(a), lipoprotein(a); SD, standard deviation; TC, total cholesterol; TG, triglycerides.

HHS Vulnerability Disclosure